The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
about
Cost effectiveness of contraceptives in the United StatesImproving Access to Long-Acting Contraceptive Methods and Reducing Unplanned Pregnancy Among Women with Substance Use DisordersContraception and cardiovascular diseaseInsertion of intrauterine devices after cesarean section: a systematic review update.Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5 mg in contraception.The burden of unintended pregnancies in Brazil: a social and public health system cost analysisStrategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception.A review of barriers and myths preventing the more widespread use of intrauterine contraception in nulliparous women.Achieving cost-neutrality with long-acting reversible contraceptive methods.Impact of pay for performance on prescribing of long-acting reversible contraception in primary care: an interrupted time series studyMulti-city assessment of lifetime pregnancy involvement among street youth, Ukraine.Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraceptionThe Cost-Effectiveness of Emergency Hormonal Contraception with Ulipristal Acetate versus Levonorgestrel for Minors in France.Unintended pregnancies in England in 2010: costs to the National Health Service (NHS).Fertility goal-based counseling increases contraceptive implant and IUD use in HIV-discordant couples in Rwanda and Zambia.Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation.Increasing the uptake of long-acting reversible contraception in general practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial protocol.Knowledge and factors determining choice of contraception among Singaporean women.Review of postpartum contraceptive practices at Chiang Mai University Hospital: implications for improving quality of service.Prevalence and factors predictive of long-acting reversible contraceptive use in a tertiary hospital in urban Ghana.Insertion of intrauterine contraceptive devices by registered nurses in Australia.Use of effective contraception 6 months after emergency contraception with a copper intrauterine device or ulipristal acetate - a prospective observational cohort study.Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion.Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review.User characteristics, experiences and continuation rates of copper intrauterine device use in a cohort of Australian women.Improved access increases postpartum uptake of contraceptive implants among HIV-positive women in Rwanda.The Impact of Balanced Counseling on Contraceptive Method Choice and Determinants of Long Acting and Reversible Contraceptive Continuation in Nepal.Provider and lay perspectives on intra-uterine contraception: a global review.Long-acting reversible contraception for adolescents and young adults - a cross-sectional study of women and general practitioners in Oslo, Norway.Evaluation of the usefulness of the 'hormones with optional pelvic exam' programme offered at a family planning clinic.Young women's experiences of side-effects from contraceptive implants: a challenge to bodily control.Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.Immediate postpartum use of long-acting reversible contraceptives in low- and middle-income countries.Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.Unanticipated bleeding with the etonogestrel implant: advice and therapeutic interventions.LARC methods: entering a new age of contraception and reproductive health.Is contraceptive self-injection cost-effective compared to contraceptive injections from facility-based health workers? Evidence from Uganda
P2860
Q24631004-105F676B-264B-495D-ACFD-DA6AE2B5BE2DQ26747590-C48A42A6-21C2-4699-A4B3-DEA63F2782EDQ27026895-4A29AF5C-FB7D-4C9B-8F7C-2F8C4E3969B5Q33596438-69056049-68B8-4284-99D7-C88953B126FCQ33605175-DD043668-E4B1-4DB9-AEFF-C40131E1D9B5Q33933835-56927590-EFCE-44EA-A237-C9774709C794Q34126221-D426DAD2-E7FC-4202-B25D-16485408C220Q34290404-EE8304DF-30A5-495B-8247-9130C9BA694AQ34714453-5ACFDB07-883C-4BB1-8FDA-EE5901BCCC3DQ35138280-7CD05F42-34F7-41B8-8D57-8A9BC3757D18Q35168849-C77723E7-D5AB-4CE9-AF71-91120B9CA50AQ35208014-286DC903-F418-4772-8CC6-2EBAD4845CAFQ35793712-163823EB-1667-4AF3-A4F3-10D71E5267D6Q36395154-D9B3C308-82F3-438E-AD15-D44116EF2DC3Q36763732-7A15B7A3-479B-4B5A-AFC4-945CD2E44EFDQ36975113-4ACAB482-AB7E-4CA6-BC03-44618B3E4623Q37355874-5B13B645-A331-4B82-B3A7-2F44E2CD00F9Q37672559-DEF6BA0D-A92C-42C8-AC10-E85E56348A8AQ37957729-86A3D133-69BB-41C7-A5C8-2EA6438380F4Q38104732-44D54D93-DDCB-41C2-AF33-3C03123247F6Q38667838-DEC7D23F-7DCB-4EAC-988D-FFA7BF4A399EQ38876684-54010292-6CFC-47AC-AE94-394CFC9A193BQ38907634-683D8DFB-FD71-42A2-B329-1004673FBA17Q38966235-64C50588-10FA-43D9-8F70-2E1F648289A1Q39321726-2E77147D-598D-446A-86BD-D3A37F69F6C9Q39908663-0F83AE53-BC97-456F-B562-1D8691E04386Q39938186-C751C41B-87A7-4830-B679-E9FEAF6C4CE3Q41678171-B03E9261-4169-42DA-BDC0-738F834A1479Q43978549-401ED7B0-B345-4944-A35E-0C4E8323A23AQ44974953-612B2328-E2A9-4D1A-9493-142254C376DAQ45182135-5EC119A3-15D4-42F0-9E58-093450B98769Q46315633-F241E477-A249-4389-8FA7-4ACDA047F9EAQ47212029-052A71A1-F34F-4804-AFA4-B74CE5A010C8Q49222352-69238DAE-BD3B-4954-A952-0730017C71F5Q51822699-67012509-394E-4673-822F-2B0C4F2743DEQ55003092-40F3A8D5-DCC6-478A-A37C-1E771016F53BQ56910623-EC485272-BA68-4839-BE51-03C657AE9B1D
P2860
The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The cost-effectiveness of long ...... ) clinical practice guideline.
@ast
The cost-effectiveness of long ...... ) clinical practice guideline.
@en
The cost-effectiveness of long ...... Health and Clinical Excellence
@nl
type
label
The cost-effectiveness of long ...... ) clinical practice guideline.
@ast
The cost-effectiveness of long ...... ) clinical practice guideline.
@en
The cost-effectiveness of long ...... Health and Clinical Excellence
@nl
prefLabel
The cost-effectiveness of long ...... ) clinical practice guideline.
@ast
The cost-effectiveness of long ...... ) clinical practice guideline.
@en
The cost-effectiveness of long ...... Health and Clinical Excellence
@nl
P356
P1433
P1476
The cost-effectiveness of long ...... ) clinical practice guideline.
@en
P2093
I Mavranezouli
LARC Guideline Development Group
P304
P356
10.1093/HUMREP/DEN091
P407
P577
2008-03-26T00:00:00Z